Melissa Gilliam

ORCID: 0000-0003-4881-3572 · 1 paper in corpus

rct 2022

Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens

Contraception ·doi:10.1016/j.contraception.2022.04.002

OBJECTIVES: To describe ovulation inhibition and safety of daily oral ulipristal acetate (UPA) over 84 days. STUDY DESIGN: This multi-center phase 1 and/or 2 trial randomized participants to use oral ulipristal 10 mg or 5 mg daily or a 3 c…